盐酸氨溴索雾化吸入治疗COPD的临床分析

The respimat therapy of amhraxoihydrochioride used for patients with COPD

目的：探讨雾化吸入盐酸氨溴索治疗COPD的临床效果。方法：90例COPD患者随机分为实验组和对照组，对照组给予综合治疗，实验组在对照组基础上给予雾化吸入盐酸氨溴索治疗。结果：实验组显效率和总有效率显著高于对照组（x2=5．840，P〈0．05；X2=6．386，P〈0．05），临床症状改善时间显著短于对照组（t=3．174，P〈0．05）。结论：综合治疗结合盐酸氨溴索雾化吸入辅助治疗，能显著提高治疗效果，缩短治疗时间，值得临床考虑。

Objective： To explore the clinical effect of respimat therapy of ambroxolhydrochloride used for patients with COPD. Methods： 151 cases of patients with COPD were randomly divided into experimental group and control group. Control groups were given comprehensive treatment~ and experi- mental group were added to respimat therapy of ambroxoihydrochloride on base of control group. 1Results： The excellent rate and total effective rate in ex- perimental group was significantly higher than that in control group（X2 = 5. 840, p〈0.05 ; X2 = 6. 386, p〈0.05）, the improving time of clinical syndrome in experimental group was significantly shorter, too（t=3.174,p〈0.05）. Conclusion： Comprehensive treatment combined with resplmat therapy of ambr- oxolhydrochloride used for COPD,can significantly enhance clinical effect and shorten therapy time, so it deserved considering in clinical work.